Literature DB >> 31196609

Ion channels and transporters in diabetic kidney disease.

Denisha Spires1, Anna D Manis1, Alexander Staruschenko2.   

Abstract

Type 1 and 2 diabetes mellitus are major medical epidemics affecting millions of patients worldwide. Diabetes mellitus is the leading cause of diabetic kidney disease (DKD), which is the most common cause of end-stage renal disease (ESRD). DKD is associated with significant changes in renal hemodynamics and electrolyte transport. Alterations in renal ion transport triggered by pathophysiological conditions in diabetes can exacerbate hypertension, accelerate renal injury, and are integral to the development of DKD. Renal ion transporters and electrolyte homeostasis play a fundamental role in functional changes and injury to the kidney during DKD. With the large number of ion transporters involved in DKD, understanding the roles of individual transporters as well as the complex cascades through which they interact is essential in the development of effective treatments for patients suffering from this disease. This chapter aims to gather current knowledge of the major renal ion transporters with altered expression and activity under diabetic conditions, and provide a comprehensive overview of their interactions and collective functions in DKD.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetic kidney disease; Diabetic nephropathy; ENaC; K(ATP) channel; NHE; SGLT2; TRPC6; TRPM6

Mesh:

Substances:

Year:  2019        PMID: 31196609      PMCID: PMC6815098          DOI: 10.1016/bs.ctm.2019.01.001

Source DB:  PubMed          Journal:  Curr Top Membr        ISSN: 1063-5823            Impact factor:   3.049


  219 in total

1.  Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus.

Authors:  Takashi Masuda; Misao N Ogura; Tatsumi Moriya; Naonobu Takahira; Takuya Matsumoto; Toshiki Kutsuna; Miyako Hara; Naoko Aiba; Chiharu Noda; Tohru Izumi
Journal:  Cardiovasc Ther       Date:  2011-02       Impact factor: 3.023

2.  SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.

Authors:  Xiaoxin X Wang; Jonathan Levi; Yuhuan Luo; Komuraiah Myakala; Michal Herman-Edelstein; Liru Qiu; Dong Wang; Yingqiong Peng; Almut Grenz; Scott Lucia; Evgenia Dobrinskikh; Vivette D D'Agati; Hermann Koepsell; Jeffrey B Kopp; Avi Z Rosenberg; Moshe Levi
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

Review 3.  Sodium-glucose cotransport.

Authors:  Søren Brandt Poulsen; Robert A Fenton; Timo Rieg
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

Review 4.  Glucose transporters in the 21st Century.

Authors:  Bernard Thorens; Mike Mueckler
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

5.  LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose.

Authors:  David R Powell; Melinda Smith; Jennifer Greer; Angela Harris; Sharon Zhao; Christopher DaCosta; Faika Mseeh; Melanie K Shadoan; Arthur Sands; Brian Zambrowicz; Zhi-Ming Ding
Journal:  J Pharmacol Exp Ther       Date:  2013-03-13       Impact factor: 4.030

6.  Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane.

Authors:  Joanne Marks; Nicolas J C Carvou; Edward S Debnam; Surjit K Srai; Robert J Unwin
Journal:  J Physiol       Date:  2003-09-08       Impact factor: 5.182

7.  The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease.

Authors:  Masahiro Eriguchi; Ellen A Bernstein; Luciana C Veiras; Zakir Khan; Duo Yao Cao; Sebastien Fuchs; Alicia A McDonough; Jorge E Toblli; Romer A Gonzalez-Villalobos; Kenneth E Bernstein; Jorge F Giani
Journal:  J Am Soc Nephrol       Date:  2018-09-05       Impact factor: 10.121

8.  Genome-Wide Meta-Analysis Unravels Interactions between Magnesium Homeostasis and Metabolic Phenotypes.

Authors:  Tanguy Corre; Francisco J Arjona; Caroline Hayward; Sonia Youhanna; Jeroen H F de Baaij; Hendrica Belge; Nadine Nägele; Huguette Debaix; Maxime G Blanchard; Michela Traglia; Sarah E Harris; Sheila Ulivi; Rico Rueedi; David Lamparter; Aurélien Macé; Cinzia Sala; Stefania Lenarduzzi; Belen Ponte; Menno Pruijm; Daniel Ackermann; Georg Ehret; Daniela Baptista; Ozren Polasek; Igor Rudan; Toby W Hurd; Nicholas D Hastie; Veronique Vitart; Geràrd Waeber; Zoltán Kutalik; Sven Bergmann; Rosa Vargas-Poussou; Martin Konrad; Paolo Gasparini; Ian J Deary; John M Starr; Daniela Toniolo; Peter Vollenweider; Joost G J Hoenderop; René J M Bindels; Murielle Bochud; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2017-11-01       Impact factor: 10.121

Review 9.  Glucose Transporters in Diabetic Kidney Disease-Friends or Foes?

Authors:  Anita A Wasik; Sanna Lehtonen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-09       Impact factor: 5.555

10.  KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways.

Authors:  Chunling Huang; Mike Z Lin; Delfine Cheng; Filip Braet; Carol A Pollock; Xin-Ming Chen
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

View more
  5 in total

1.  NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease.

Authors:  Tengis S Pavlov; Oleg Palygin; Elena Isaeva; Vladislav Levchenko; Sherif Khedr; Gregory Blass; Daria V Ilatovskaya; Allen W Cowley; Alexander Staruschenko
Journal:  FASEB J       Date:  2020-08-16       Impact factor: 5.191

Review 2.  Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications.

Authors:  Federica Piani; Isabella Melena; Kalie L Tommerdahl; Natalie Nokoff; Robert G Nelson; Meda E Pavkov; Daniël H van Raalte; David Z Cherney; Richard J Johnson; Kristen J Nadeau; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2020-12-31       Impact factor: 2.852

Review 3.  Postprandial effects on electrolyte homeostasis in the kidney.

Authors:  Christine A Klemens; Michael W Brands; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-30

Review 4.  Critical Role for AMPK in Metabolic Disease-Induced Chronic Kidney Disease.

Authors:  Florian Juszczak; Nathalie Caron; Anna V Mathew; Anne-Emilie Declèves
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

5.  Role of opioid signaling in kidney damage during the development of salt-induced hypertension.

Authors:  Daria Golosova; Oleg Palygin; Ruslan Bohovyk; Christine A Klemens; Vladislav Levchenko; Denisha R Spires; Elena Isaeva; Ashraf El-Meanawy; Alexander Staruschenko
Journal:  Life Sci Alliance       Date:  2020-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.